Product Information
DULOXETINE HCL DR 30 MG CAP is a generic product labeled by Breckenridge Pharmaceutical Inc., priced at $0.1008 per EA under NDC 51991074790. Its NADAC has been published 625 times since Jul 9, 2014.
Strength
30 mg/1
Manufacturer
Breckenridge Pharmaceutical Inc.NDC
51991074790
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE PELLETS
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DULOXETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203088On Market Since
6/11/2014
Pharmacological Classes
Price Statistics
The NADAC for DULOXETINE HCL DR 30 MG CAP has been published 625 times since Jul 9, 2014, and over the history we have for it it has declined 98.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1008 per EA |
|---|---|
| All-time high | $5.2597 (Aug 13, 2014) |
| All-time low | $0.0696 (May 22, 2024) |
| 52-week high | $0.1008 |
| 52-week low | $0.0773 |
| Median price | $0.1485 |
| Average price | $0.3233 |
| Largest weekly change | -55.4% (Sep 17, 2014) |
| Weeks tracked | 625 |
| Tracking since | Jul 9, 2014 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DULOXETINE HCL DR 30 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DULOXETINE HCL DR 30 MG CAP, manufactured by Breckenridge Pharmaceutical Inc., is $0.1008 per EA (NDC 51991074790), effective Jun 24, 2026.
How has the price of DULOXETINE HCL DR 30 MG CAP changed over time?
Over the history we have for it, the NADAC for DULOXETINE HCL DR 30 MG CAP has declined 98.1%. It has been tracked across 625 weekly CMS publications since Jul 9, 2014.
What are the highest and lowest recorded NADAC prices for DULOXETINE HCL DR 30 MG CAP?
Since Jul 9, 2014, the NADAC for DULOXETINE HCL DR 30 MG CAP has ranged from a low of $0.0696 (May 22, 2024) to a high of $5.2597 (Aug 13, 2014), with a median of $0.1485 per EA.
Are there cheaper alternatives to DULOXETINE HCL DR 30 MG CAP?
2 NADAC-published products share the same active ingredient, strength, and dosage form as DULOXETINE HCL DR 30 MG CAP, but none are currently priced below it.
Who manufactures DULOXETINE HCL DR 30 MG CAP?
DULOXETINE HCL DR 30 MG CAP (NDC 51991074790) is labeled by Breckenridge Pharmaceutical Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification